What Are Enterocytes and What Is Their Function?

Enterocytes are the most abundant cell type lining your small intestine, and their primary job is absorbing nutrients from the food you eat. These tall, column-shaped cells carpet the finger-like projections called villi that give the intestinal lining its shaggy, towel-like texture. But nutrient absorption is only one part of what enterocytes do. They also form a selective physical barrier against bacteria and toxins, participate in immune defense, metabolize drugs before they ever reach your bloodstream, and turn over so rapidly that you get a functionally new intestinal lining every few days.

How Enterocytes Are Built for Absorption

An enterocyte is among the most structurally specialized cells in the body. Its defining feature is extreme polarity: the top surface (facing the gut lumen where food passes) looks and behaves completely differently from the bottom surface (facing the blood supply). The top, or apical, surface is covered with thousands of tightly packed, finger-like projections called microvilli, which together form what’s known as the brush border. Each microvillus is supported internally by a scaffold of actin filaments, and collectively they dramatically increase the surface area available for absorbing nutrients.

1PubMed Central. Shaping the intestinal brush border

The microvilli are remarkably uniform in height, giving the brush border its characteristic appearance under a microscope. Coating these microvilli is a carbohydrate-rich mesh called the glycocalyx, anchored at the tips. This combination of structural precision and chemical specialization makes enterocytes among the most highly polarized cells that exist. Different proteins and enzymes are sorted to the apical versus basolateral (bottom and side) surfaces, ensuring that nutrients flow in one direction: from the gut lumen, through the cell, and out into the blood or lymph on the other side.

2PubMed. Epithelial cell polarity as reflected in enterocytes

How Sugars Get Absorbed

Carbohydrate absorption through enterocytes illustrates how precisely these cells manage transport. By the time starches and sugars reach the small intestine, digestive enzymes have broken them down into simple sugars, mainly glucose, galactose, and fructose. Each enters the enterocyte through specific transporter proteins sitting on the brush border membrane.

The transporter responsible for most glucose and galactose uptake is called SGLT1. It works by hitching a ride on sodium ions that flow down their concentration gradient into the cell, dragging glucose or galactose along. In animal studies, knocking out SGLT1 reduced intestinal glucose absorption by roughly 80%, confirming its dominant role.

3PLOS ONE. The Role of SGLT1 and GLUT2 in Intestinal Glucose Transport and Sensing

Fructose, meanwhile, enters through a different transporter called GLUT5, which sits alongside SGLT1 on the brush border.

Getting sugar into the cell is only half the job. Once inside, glucose needs to exit through the basolateral membrane into the bloodstream. That exit door is mainly a transporter called GLUT2, which sits on the blood-facing side of the enterocyte. When researchers studied mice lacking GLUT2, glucose accumulated inside intestinal tissue at levels about 55% higher than normal, because it had no efficient way out. The result was a roughly 40% drop in plasma glucose after a meal.

3PLOS ONE. The Role of SGLT1 and GLUT2 in Intestinal Glucose Transport and Sensing

This two-step system, with distinct entry and exit transporters, gives enterocytes fine-grained control over how quickly sugars reach the blood.

4PubMed Central. Glucose transporters in the small intestine in health and disease

Proteins, Fats, Iron, and Vitamins

Sugar transport is just one chapter in the enterocyte’s absorption story. These cells handle an extraordinary range of nutrients, each with its own dedicated transport machinery.

Protein breakdown products, mostly small peptide fragments of two or three amino acids, cross the brush border through a transporter called PEPT1. This single transporter can handle an enormous variety of peptide combinations, making it remarkably efficient. It’s also medically relevant: several classes of drugs, including common antibiotics like beta-lactams, are shaped enough like peptides that PEPT1 carries them into the body as well.

5PubMed. Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1

Fat absorption takes a different route entirely. After bile salts and pancreatic enzymes break dietary fats into fatty acids and monoglycerides, these lipid molecules pass across the brush border membrane, which is itself a lipid bilayer, relatively easily. Inside the enterocyte, the cell reassembles these components into large lipoprotein particles called chylomicrons, a complex, multi-step process regulated by hormones and internal signaling pathways.

6PubMed Central. Regulation of Chylomicron Secretion: Focus on Post-Assembly Mechanisms

Chylomicrons are too large to squeeze into the capillaries that collect water-soluble nutrients, so instead they’re secreted into the lymphatic system and eventually reach the bloodstream through larger vessels. Enterocytes also stash some dietary fat in internal lipid droplets for later release, a phenomenon researchers call the “second-meal effect” because fat from one meal can influence lipid levels after the next.

7Journal of Lipid Research. What Are Enterocytes and What Is Their Function? – Section: The Apical Track

Iron absorption is handled by mature enterocytes at the tips of villi in the duodenum, the first stretch of the small intestine. Two transporters, DMT1 and HCP1, move dietary iron across the brush border.

8PubMed Central. The role of hepcidin, ferroportin, HCP1, and DMT1 protein in iron absorption in the human digestive tract

Interestingly, calcium competes with iron at this step: high calcium intake can reduce the amount of DMT1 available on the brush border, decreasing how much iron gets into the cell. This is why nutrition advice sometimes suggests separating iron supplements from dairy or calcium pills.

9PubMed. Inhibitory effect of calcium on non-heme iron absorption may be related to translocation of DMT-1 at the apical membrane of enterocytes

Vitamin B12 absorption depends on enterocytes much further down the intestinal tract, in the distal ileum. A receptor complex made up of two proteins, cubilin and amnionless, mediates the uptake of B12 that has already been bound to a carrier protein called intrinsic factor. This is why diseases or surgeries affecting the last section of the small intestine can cause B12 deficiency even when dietary intake is adequate.

The Barrier That Keeps the Inside In and the Outside Out

Your intestine contains an enormous population of bacteria, viruses, dietary antigens, and potential toxins. Enterocytes form the front line of defense against all of them, not through immune firepower but through sheer physical barrier function.

Adjacent enterocytes are connected near their apical surface by tight junctions, protein complexes that seal the gaps between cells. These junctions regulate what can slip through the spaces between cells, the so-called paracellular pathway. Tight junctions are not simple gaskets. They can function as absolute barriers in some circumstances and as selective ion channels in others, allowing fine-tuned control over what crosses the epithelial sheet.

10PubMed Central. Tight junctions: from molecules to gastrointestinal diseases

When tight junctions break down, you get increased intestinal permeability, sometimes called “leaky gut” in popular health media. The clinical reality is more specific: disrupted tight junctions allow molecules and even bacteria to cross from the gut lumen into underlying tissue, triggering inflammation. This process is a recognized feature of conditions like celiac disease and inflammatory bowel disease, where the barrier fails in ways researchers can measure. Tight junction dysfunction can allow ions, macromolecules, and even whole cells to pass through the paracellular route inappropriately.

11PubMed Central. Enterocytes’ tight junctions: From molecules to diseases

Enterocytes and Immune Defense

Beyond acting as a passive wall, enterocytes actively participate in immune protection. One of their key immune roles involves transporting antibodies. Immune cells in the tissue beneath the intestinal lining produce a type of antibody called secretory IgA (and, to a lesser extent, IgM). These antibodies need to reach the gut lumen to coat bacteria and toxins before they can cause harm. Enterocytes accomplish this through a protein called the polymeric immunoglobulin receptor, or pIgR, which picks up IgA at the blood-facing side, ferries it through the cell, and releases it on the gut-facing side.

12PubMed Central. Role of Polymeric Immunoglobulin Receptor in IgA and IgM Transcytosis

This secretory IgA system is the body’s largest antibody-producing operation. Once in the gut lumen, IgA coats bacteria and other microbes, preventing them from attaching to the intestinal wall and helping maintain a stable, cooperative relationship between you and your gut microbiota.

13PubMed Central. Cooperativity among secretory IgA, the polymeric immunoglobulin receptor, and the gut microbiota promotes host-microbial mutualism

What Enterocytes Eat

Given how much work enterocytes do, they need a lot of energy. What’s surprising is where they get it. You might assume intestinal cells would burn glucose, since they sit at the site where dietary glucose is most concentrated. Instead, enterocytes rely heavily on amino acids, especially glutamine and glutamate, as their preferred fuel. Studies in enterocyte mitochondria have shown that glutamate and glutamine oxidation is robust and supported by the co-substrate malate, which boosted their oxidation rates by about 76% to 93% respectively.

14PubMed Central. The oxidation of glutamine and glutamate in relation to anion transport in enterocyte mitochondria

Research in developing chickens found that among all substrates tested, glutamate had the highest oxidation rate in enterocytes across all age groups studied, outpacing glutamine, aspartate, alanine, and various fatty acids.

15PubMed Central. Oxidation of amino acids, glucose, and fatty acids as metabolic fuels in enterocytes of post-hatching developing chickens

This preference for amino acid fuel rather than glucose makes metabolic sense: enterocytes channel much of the glucose they absorb directly into the bloodstream for the rest of the body, rather than consuming it themselves. The species-specific details vary; ruminant enterocytes, for instance, may rely on glutamine somewhat less than their non-ruminant counterparts.

16PubMed. Oxidation of glucose, glutamate, and glutamine by isolated ovine enterocytes in vitro is decreased by the presence of other metabolic fuels

A New Lining Every Few Days

Enterocytes have one of the shortest lifespans of any cell in the body. The entire lining of the small intestine is completely replaced every three to five days. Stem cells at the bottom of tiny pits called crypts divide continuously, and their daughter cells migrate upward along the villi, maturing into functional enterocytes as they go. By the time a cell reaches the tip of a villus, it is fully differentiated and working at peak capacity. Shortly after, it undergoes programmed cell death and is shed into the gut lumen.

17PubMed Central. PGC-1β promotes enterocyte lifespan and tumorigenesis in the intestine

This rapid turnover is a double-edged sword. On one hand, it means the intestinal lining can recover quickly from minor damage, infections, and toxic insults. On the other, it makes the gut lining one of the first casualties of treatments that target rapidly dividing cells, such as chemotherapy. The nausea, diarrhea, and malabsorption that often accompany cancer treatment are partly a consequence of enterocyte loss outpacing regeneration.

The renewal system also depends on balance. If stem cell division becomes dysregulated, excessive proliferation can lead to intestinal tumors. Molecular regulators that control how long enterocytes live and when they die are actively studied for their role in colorectal cancer.

When Enterocytes Fail

Several diseases directly target enterocytes or the systems that support them. In celiac disease, the immune system mounts an attack on the intestinal lining in response to gluten. In its most severe form, refractory celiac disease type II, abnormal immune cells lodged within the epithelium produce a cell-killing enzyme called granzyme B that destroys surrounding enterocytes. Patients who don’t respond to treatment and have persistent villous atrophy show significantly higher levels of granzyme B than patients who achieve recovery.

18PubMed Central. Aberrant intra‐epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103 ‐β7‐receptor‐mediated granzyme‐B degranulation which can be restored by etrolizumab

The villous atrophy seen in celiac disease is a direct consequence of enterocyte destruction: when enough cells are killed, the villi flatten, reducing surface area and leading to malabsorption of nutrients across the board. Iron, calcium, fat-soluble vitamins, and B12 are often the first deficiencies to appear.

Infections can also devastate enterocytes. Rotavirus, one of the most common causes of severe diarrhea in young children worldwide, targets enterocytes directly, infecting and destroying them. The resulting loss of absorptive surface area, combined with disrupted ion and water transport, produces the watery diarrhea that defines the illness.

Age takes a toll on enterocytes as well. As people grow older, the intestinal epithelium undergoes changes that may contribute to age-related shifts in gut bacteria, chronic low-grade inflammation, and declining immune function. Researchers have proposed that age-associated dysfunction of the intestinal epithelium, including enterocytes, may play a central role in propagating these interconnected changes.

Enterocytes as Drug Gatekeepers

When you swallow a pill, the drug doesn’t simply pass through the gut wall and into your blood unchanged. Enterocytes are equipped with a set of drug-metabolizing enzymes and efflux pumps that can break down or eject medications before they ever reach the general circulation. This “intestinal first-pass effect” is a major reason why some drugs have low oral bioavailability, meaning only a fraction of the dose you swallow actually makes it into your bloodstream in active form.

19PubMed Central. An update on the role of intestinal cytochrome P450 enzymes in drug disposition

The main enzyme responsible is CYP3A4, the same enzyme that handles a large portion of drug metabolism in the liver. In the intestine, CYP3A4 is concentrated in the enterocytes at the tips of villi, exactly where absorption occurs. Working alongside it is a protein called P-glycoprotein (P-gp), an efflux pump that sits on the brush border and actively pushes absorbed drug molecules back out into the gut lumen.

20PubMed. The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein

CYP3A4 and P-glycoprotein share many of the same drug substrates, are located in the same cells, and can even be switched on together by the same triggers. Researchers have proposed that P-glycoprotein may slow drug absorption just enough to give CYP3A4 more time to break the drug down, effectively making the two work as a coordinated team to limit how much active drug gets through.

21Advanced Drug Delivery Reviews. The barrier function of CYP3A4 and P-glycoprotein in the small bowel

This is why grapefruit juice affects so many medications. Compounds in grapefruit inhibit intestinal CYP3A4, allowing more drug to pass through enterocytes intact and producing higher, sometimes dangerously higher, blood levels.

Why Location Along the Intestine Matters

Not all enterocytes are the same. Cells in the duodenum, jejunum, and ileum express different transporters and enzymes suited to the nutrients that arrive at each stage of digestion. Iron absorption is concentrated in the duodenum, where dietary iron arrives first. Glucose and amino acid absorption peaks in the jejunum, where the bulk of digested carbohydrate and protein is available. Vitamin B12 and bile salts are absorbed almost exclusively in the distal ileum, which is why surgical removal of this section creates specific, predictable deficiencies.

CYP3A4 and P-glycoprotein levels also vary along the intestine, generally being highest in the proximal small bowel and declining toward the ileum. The overlap of high enzyme activity and high absorptive capacity in the jejunum is one reason the intestinal first-pass effect is so significant for many oral drugs. Researchers have suggested that P-glycoprotein may even shift drug absorption toward more distal segments where CYP3A4 levels are lower, reducing the fraction of drug that gets metabolized and adding another layer of complexity to how enterocytes control what enters the body.

21Advanced Drug Delivery Reviews. The barrier function of CYP3A4 and P-glycoprotein in the small bowel

The gradient of enterocyte function along the intestine also has implications for diseases and surgeries. Crohn’s disease, which often targets the ileum, can selectively impair B12 and bile salt absorption while leaving sugar and amino acid uptake relatively intact. Short bowel syndrome, where large segments of intestine are removed, produces different nutritional consequences depending on which region was lost. Understanding what enterocytes do at each location helps explain why these conditions behave the way they do and why nutritional support has to be tailored to the specific anatomy left behind.